Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations (Q38248399)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 September 2014

Language	Label	Description	Also known as
English	Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations	scientific article published on 12 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

1 September 2017

1 reference

Europe PubMed Central

Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations (English)

1 reference

Europe PubMed Central

1 September 2017

Sebastian Schneeweiss

4

object named as

Sebastian Schneeweiss

1 reference

Europe PubMed Central

1 September 2017

8

object named as

John D Seeger

1 reference

Europe PubMed Central

1 September 2017

author name string

Elisabetta Patorno

1

1 reference

Europe PubMed Central

1 September 2017

Amanda R Patrick

2

1 reference

Europe PubMed Central

1 September 2017

Elizabeth M Garry

3

1 reference

Europe PubMed Central

1 September 2017

Victoria G Gillet

5

1 reference

Europe PubMed Central

1 September 2017

Dorothee B Bartels

6

1 reference

Europe PubMed Central

1 September 2017

Elvira Masso-Gonzalez

7

1 reference

Europe PubMed Central

1 September 2017

publication date

12 September 2014

1 reference

Europe PubMed Central

1 September 2017

1 reference

Europe PubMed Central

1 September 2017

57

1 reference

Europe PubMed Central

1 September 2017

11

1 reference

Europe PubMed Central

1 September 2017

2237-2250

1 reference

Europe PubMed Central

1 September 2017

https://scigraph.springernature.com/pub.10.1007/s00125-014-3364-z

0 references

A review of uses of health care utilization databases for epidemiologic research on therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

A basic study design for expedited safety signal evaluation based on electronic healthcare data

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Immortal time bias in pharmaco-epidemiology

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Relationship between cumulative dose of thiazolidinediones and clinical outcomes in type 2 diabetic patients with history of heart failure: a population-based cohort study in Taiwan

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Effects of thiazolidinediones on cardiovascular events in patients with type 2 diabetes mellitus after drug-eluting stent implantation: a retrospective cohort study using the national health insurance database in Taiwan

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Increased mortality in Type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Insulin use and increased risk of mortality in type 2 diabetes: a cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Thiazolidinediones and congestive heart failure in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Effect of rosiglitazone on survival in patients with diabetes mellitus treated for coronary artery disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Association between serious ischemic cardiac outcomes and medications used to treat diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

The incidence of congestive heart failure associated with antidiabetic therapies

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Pioglitazone initiation and subsequent hospitalization for congestive heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Risk of cardiovascular events and all-cause mortality in patients treated with thiazolidinediones in a managed-care population

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Chronic heart failure-related interventions after starting rosiglitazone in patients receiving insulin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Overadjustment bias and unnecessary adjustment in epidemiologic studies

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Risk and Short-Term Prognosis of Myocardial Infarction Among Users of Antidiabetic Drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Association between extent of thiazolidinedione exposure and risk of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Rosiglitazone and myocardial infarction in patients previously prescribed metformin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Cancer risk in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

The incident user design in comparative effectiveness research.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Comparison of cardiovascular outcomes in elderly patients with diabetes who initiated rosiglitazone vs pioglitazone therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Beyond the intention-to-treat in comparative effectiveness research

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Marginal structural models and causal inference in epidemiology

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Channeling bias in the interpretation of drug effects

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project)

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Incidence of new coronary events in older persons with diabetes mellitus and prior myocardial infarction treated with sulfonylureas, insulin, metformin, and diet alone

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Rosiglitazone is associated with mortality in chronic hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

A simulation study of the number of events per variable in logistic regression analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

The central role of the propensity score in observational studies for causal effects

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

The validity of medicaid pharmacy claims for estimating drug use among elderly nursing home residents: The Oregon experience

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Validating administrative data in stroke research

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

A systematic review of validated methods for identifying heart failure using administrative data

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Diabetes therapy and cancer risk: causal effects and other plausible explanations

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Metformin and the risk of cancer: time-related biases in observational studies

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3364-Z

21 January 2018

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confounding by indication

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recall accuracy for prescription medications: self-report compared with database information

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular events and insulin therapy: a retrospective cohort analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-sensitizing antihyperglycaemic medications are associated with better outcome in patients with diabetes undergoing cardiac stress testing

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantifying biases in causal models: classical confounding vs collider-stratification bias.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary heart disease outcomes in patients receiving antidiabetic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The incidence of congestive heart failure in type 2 diabetes: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Record linkage studies for postmarketing drug surveillance: data quality and validity considerations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sulfonylurea drugs do not influence initial stroke severity and in-hospital outcome in stroke patients with diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral antidiabetic treatment in patients with coronary disease: time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trials analyzed as observational studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Completeness of prescription recording in outpatient medical records from a health maintenance organization

1 reference

https://pubmed.ncbi.nlm.nih.gov/25212258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-014-3364-Z

1 reference

Europe PubMed Central

1 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38248399&oldid=1749281077"